A study by Jennifer Estall and Aurèle Besse-Patin explores how female mice respond to FGF21, a hormone that improves metabolism and insulin sensitivity. The researchers aim to provide a more comprehensive understanding of the effect of sex on drug treatment for metabolic diseases.
A study by IRCM researchers has discovered a mechanism that controls the production of neurons from stem cells. This discovery could lead to more effective cell therapies and targeted treatments against cancer, particularly in diseases causing blindness where specific retinal cells degenerate.
Researchers at IRCM identified the mechanism of action for a new target in immune-oncology treatments, focusing on natural killer cells and DNAM-1 protein. The discovery could lead to improved therapies using antibodies against TIGIT receptor.
Researchers discovered HIV exploits regulatory process between BST2 and ILT7 to limit antiviral response, allowing virus to spread and persist in long-lasting reservoirs. Blocking Vpu's action could prevent early viral expansion and dissemination, enabling pDCs to trigger effective antiviral responses.
A Montréal research team found that the dual-hormone artificial pancreas provides the most benefits by reducing time spent in nocturnal hypoglycaemia. The study also showed that no participant using the system experienced a nocturnal hypoglycaemia event requiring treatment.
A team of researchers at the IRCM has made a breakthrough discovery about how DNA is organized in our cells. They found that two specific proteins play an essential role in maintaining the proper structure of chromatin.
A breakthrough study published in The Journal of Neuroscience reveals the critical role of a gene associated with a rare disease in pain processing. Lmx1b mutations cause reduced pain responses in patients, but removing this gene only in the spinal cord allows mice to survive, yet results in reduced sensitivity to stimuli.
Researchers at the IRCM have discovered a new mechanism affecting AID, a crucial enzyme for the immune response, which could lead to improved treatment for the common flu, as well as lymphoma and leukemia. The study identified a protein eEF1a that retains AID in the cell's cytoplasm, allowing it to access the nucleus and boost activity.
Researchers at IRCM have uncovered a new synergy mechanism required for neural circuits to form properly. This breakthrough may lead to the development of tools to repair nerve cells following injuries to the nervous system.
Researchers at IRCM have discovered a mechanism that regulates dopamine levels in the brain, which could lead to new treatments for Parkinson's disease. The Rgs6 gene plays a crucial role in preventing excessive dopaminergic signalling and cellular stress.
Researchers at IRCM identified a protein called Miz-1 that controls the activity of p53 tumour suppressor protein, essential for developing immune cells. Without Miz-1, lymphocytes prematurely activate p53 and die, hindering the immune response.
Researchers at IRCM uncover the essential role of a protein called Numb in maintaining proper compartmentalization within photoreceptor cells, leading to vision loss and degenerative diseases like retinitis pigmentosa. The discovery could provide novel drug targets for preventing photoreceptor degeneration.
Researchers at IRCM discovered that a protein called Sonic Hedgehog induces DNA damage, which promotes the progression of medulloblastoma, the most common brain tumor found in children. The study found that Boc receptor is required for Sonic Hedgehog to induce DNA mutations, reducing tumour growth by 66%.
A new report by IRCM ethics experts highlights the need for increased regulation and oversight of neurostimulation techniques like tDCS. The report found a mismatch between academic and print media articles on tDCS, with most media coverage focusing on potential enhancement uses rather than therapeutic limitations.
Researchers at the Institut de recherches cliniques de Montréal have discovered how the immune system kills abnormal blood cells. The study found that EAT-2 and SAP molecules work together to activate natural killer cells, which play a crucial role in protecting against viruses and cancer cells.
IRC Researchers discover a new function of AID, an enzyme crucial for the immune response. This finding helps explain hyper-IgM syndrome type 2 (HIGM2), a rare genetic disorder that causes an immunodeficiency syndrome.
A study by Montreal researchers found a significant link between exposure to persistent organic pollutants (POPs) and certain metabolic complications of obesity. The study, published in the Journal of Clinical Endocrinology & Metabolism, suggests that metabolically healthy but obese individuals have lower circulating levels of POPs tha...
Researchers at IRCM identified a critical receptor in muscle cell fusion, which could lead to new therapies for muscular diseases like myopathies and muscular dystrophies. The discovery sheds light on the complex process of muscle development and regeneration.
A study by IRCM neuroethics experts highlights shortcomings in transitional care, particularly among youth with complex health needs and disabilities. The research emphasizes the importance of respectful care, autonomy support, and personalized approaches to address transition challenges.
Researchers at IRCM, in collaboration with McGill University, reveal the importance of DNA architecture in controlling gene activity, especially during embryonic development. This discovery could significantly impact genetic disease diagnosis and treatment.
A study discovered that PGC-1α, a protein regulating energy production in cells, may contribute to the development of type 2 diabetes. Chronically low levels of this protein in muscle tissue were linked to increased risk and detrimental effects on other tissues, including inflammation in the liver and adipose tissue.
A team of Montréal researchers discovered that the protein PC7 plays a critical role in the brain by affecting cognitive performance such as anxiety, learning, and emotional memory. The study found that mice lacking PC7 had impaired episodic and emotional memories, while exhibiting increased levels of dopamine in the brain.
Large pharmacogenomic studies have inconsistent results due to lack of standardization in experimental assays and data analysis methods. Standardization is necessary to identify reliable genomic predictors of drug response and effectively identify a drug's mechanism of action.
A team of researchers led by Dr. Michel Cayouette identified a group of proteins crucial for shaping the cellular organ responsible for detecting sounds in the inner ear. These proteins play a key role in creating the V-shaped brush on sensory cells, which is critical for sound detection and orientation.
Researchers at the IRCM isolated two important mechanisms that improve antibody quality, providing a new model for studying auto-immune diseases. The study found that these mechanisms, class switching and affinity maturation, are crucial for immune responses to infections and diseases.
Researchers at IRCM identified the DOCK1 protein as a key regulator of metastasis in breast cancer. The study found that eliminating DOCK1 in mice resulted in a significant decrease in lung metastases and tumor growth.
Scientists have identified a molecule called Gfi1 that represents the disease's Achilles' heel and could be targeted to develop a new approach. This discovery has direct implications for the treatment of acute lymphoblastic leukemia, a cancer of the bone marrow and blood that progresses rapidly.
Researchers developed an artificial pancreas that simulates normal pancreatic function by adapting insulin delivery based on changes in glucose levels. The system showed a 15% improvement in glucose control and significantly reduced the risk of hypoglycemia compared to conventional insulin pump therapy.
A Canadian medical journal report argues that physicians should consider refusing to prescribe cognitive enhancers to healthy people. The authors suggest that the risks and regulations of prescription drugs outweigh the potential benefits of enhanced mental performance, which are uncertain and may not be achieved with these substances.
A team of researchers led by Drs. Marie Kmita and James Sharpe discovered the Turing-like mechanism responsible for generating human fingers and toes through genetic studies and mathematical modeling. The study reveals that Hox genes play a crucial role in modulating this mechanism, which is essential for proper limb development.
IRC researchers led by Dr. Frédéric Charron have made a significant discovery about the internal clock of nerve cells during embryonic development, which could lead to new tools for repairing and regenerating damaged nerve cells in the central nervous system.
A team of IRCM researchers has discovered a critical mechanism of epigenetic cell programming in the pituitary gland. By reprogramming cell identity using the Pax7 gene, they identified cells expressing Pax7 protein in Cushing's disease tumours, which could lead to new pharmacological treatment options.
Researchers from IRCM, MIT, USC, and Illumina have made a significant breakthrough in the fight against muscular dystrophies, particularly myotonic dystrophy. The study provides insights into the role of muscleblind-like proteins in causing the disease and has potential applications for diagnostic tools and treatment.
New tools confirm high rates of misdiagnosis in patients with chronic disorders of consciousness. Clinicians face complex decisions regarding treatment and palliative care, requiring ethical sensitivity and awareness of evidence-based practices.
IRCMM researchers defined the genome-wide interaction between Stat3 and glucocorticoid receptor GR to control inflammation. This breakthrough sheds light on how these proteins regulate genes involved in development, metabolism, and immune response.
A team of IRCM researchers led by Dr. André Veillette has elucidated a poorly understood molecular mechanism associated with human immune disorder XLP disease.
A team of IRCM researchers confirmed the universality of essential cellular process phosphorylation of RNA polymerase II, contradicting recent genome-wide analyses. The study provides critical insights into genetic regulation and may lead to new treatments for genetic diseases and cancer.
Researchers at Institut de recherches cliniques de Montreal (IRCM) have discovered therapeutic peptides affecting mitochondria. These compounds target cell mitochondria to treat various acute and chronic diseases, including ischemia reperfusion injury and neurodegenerative conditions.
Researchers at IRCM identified a new gene modulating bone mass and potentially leading to osteoporosis. This breakthrough may help identify individuals with a greater predisposition to the disease.
A team of geneticists at IRCM discovered that the pituitary gland's secreting cells form highly-structured networks. These networks allow cells to recognize and exchange signals, supporting hormone balance and function.
Researchers at the Institut de recherches cliniques de Montréal (IRCM) have made a breakthrough in understanding how neurons connect and communicate. Drs. Artur Kania and Tzu-Jen Kao discovered that axon guidance is modulated by ligands present within the same neuron, leading to increased diversity of neuronal connections.
Researchers at the IRCM have made a significant breakthrough in understanding the Sonic Hedgehog protein's role in cancer development. The team found that specific receptors play a crucial role in transmitting signals from the protein, which could lead to new avenues for treating diseases such as cancer.
Researchers at Institut de recherches cliniques de Montréal have identified a key molecule directing axons during neural circuit formation. VEGF plays a crucial role in attracting nervous system axons, offering potential for therapies to re-grow axons after spinal cord injuries.
Recent studies on PCSK enzymes have shed light on novel functions in diseases such as cardiovascular disorders, osteoporosis, and cancer. The research has revealed that these enzymes may play a crucial role in regulating cholesterol levels and bone formation, offering potential new treatments for dyslipidemia and osteoporosis.
A team of IRCM researchers identified a new regulator, Miz-1, essential for the proper development and maturation of B cells. The discovery highlights the importance of the IL-7 signaling pathway for B-cell survival and maturation.
Researchers at IRCM identified a mechanism regulating activation-induced deaminase, which could lead to new therapies for some types of lymphoma and leukemia. The discovery found that Hsp90 inhibition destabilizes AID, preventing uncontrolled gene mutation and accelerating disease progression.
A recent IRCM breakthrough reveals a novel molecular mechanism that regulates cell motility, a key factor in tumour spread. The study identifies the ELMO protein's regulatory feature as critical in preventing uncontrolled cell migration.
Researchers at IRCM discover a protein called Gfi1b that regulates blood stem cell activity and mobilization, potentially accelerating the production of new blood cells. This breakthrough could lead to more efficient and safer stem cell therapy for leukemia patients.
A recent study by IRCM researchers revealed the crucial role of the Vpr protein in blocking cell division and triggering immune cell death during HIV infection. The findings suggest that targeting this process could lead to new potential therapeutic targets, providing a better understanding of HIV infection and AIDS.
Researchers discovered the function of PTP-PEST, a protein that stimulates T cells' participation in immune responses, potentially leading to new treatments for autoimmune diseases. The study's results suggest that suppressing PTP-PEST could prevent certain autoimmune diseases and weaken overactive immune responses.